Drug Evaluation Committee Theory and Practice of Model-based Meta Analysis in Drug Development
Data Science Expert Committee
The Drug Evaluation Committee's Data Science Subcommittee Continuing Task Force 4 in 2025 focused on the application of Model-based Meta Analysis (MBMA), which has few Japanese publications. We hope that this report will help you to understand MBMA properly and to use MBMA appropriately in your drug development in Japan. We hope it will help you to understand MBMA properly and to use it appropriately in your drug development in Japan.
Japan Pharmaceutical Manufacturers Association
Drug Evaluation Committee Data Science Subcommittee
2025 Ongoing Task Force 4
Theory and Practice of Model-based Meta Analysis in Drug Development